Aureka

Aureka Biotechnologies focuses on protein design and immunotherapy discovery through AI and high-throughput digital biotechnology, currently primarily concentrating on the development of common immunotherapies such as bispecific antibodies, CAR-T, ADCs, and difficult-to-drug targets like G protein-coupled receptors.